Rating History for Akari Therapeutics (AKTX) by Maxim Group

More Stocks Rated by Maxim Group | Latest Ratings for AKTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/8/2026 Jason McCarthy Downgrade Hold
(Buy)		 N/A
(N/A)		 3.80
(10.25)		 169.74% Details